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ation by Ross and Somerville3 in 1966, were also used for
the correction of truncus arteriosus in 19684 and to repair
complex forms of D-transposition of the great vessels, in
which case the procedure became known as the “Rastelli”
operation.5 Because this first generation of generally irra-
diated homografts became rapidly calcified and obstruc-
tive6 and their collection became increasingly difficult,
Dacron conduits containing porcine aortic valves were
ultimately introduced clinically in 1971 by Bowman,
Hancock, and Malm.7 Numerous reports have since dem-
onstrated that such substitutes, although convenient to use
and easily available, are vulnerable to secondary obstruc-
tion depending on several factors such as the initial diag-
nosis, age at implantation, original diameter of the con-
duit, and other technique-related issues.6,8 More recent
developments in the storage of homografts, such as cry-
opreservation, led to the hope for longer-term durability,
particularly in children. However, processes of cryo-
preservation, preparation, and thawing of homografts
have evolved with time and may differ from center to cen-
The concept of bypassing a completely obstructed pul-monary outflow tract, first designed experimentally by
Hurwitt1 in 1948, was applied clinically in 1964 by
Rastelli and associates2 in a patient with tetralogy of
Fallot, pulmonary atresia, and coronary–pulmonary artery
fistula, with the use of an autologous pericardial tubular
graft. Aortic homografts, first implanted in a similar situ-
Objective: This retrospective study was initiated to evaluate the long-term
results of valved prosthetic conduits implanted in the right ventricular
outflow tract in patients with complex ventricular-pulmonary discontinu-
ity. Methods: A cohort of 103 patients out of 127 (24 early deaths, 19%)
operated on between 1973 and 1996 with porcine valved conduits was
available for evaluation, with a follow-up ranging from 1 to 21.6 years
(mean follow-up 8.4 ± 6 years). A total of 74 hemodynamic studies were
performed after the operation, 50 patients having undergone at least 1
cardiac catheterization during the follow-up period. Results: There were
16 late deaths, and the actuarial survivals, including early mortality, were
72.9% ± 4% at 5 years, 63.1% ± 5% at 10 years, and 58.2% ± 5% at 15
years, at which time 20 patients were still available for review and exposed
to the risk of dying. The mean peak systolic gradient across the right ven-
tricular outflow tract was plotted as a function of time, showing a gradual
increase and a significant step-up after the eighth year, from 43 ± 36 to 69
± 19 mm Hg (P < .005). Reoperation was required for progressive conduit
obstruction between 1.1 and 17.7 years after implantation (mean 7.4 ± 4.8
years) in 25 patients (24%, 70% CL 15%-33%), with generally very few
symptoms, or for residual ventricular septal defect in 3 patients. Freedom
from reoperation was 79.5% ± 5% at 10 years and 65.8% ± 7% at 15
years. Conclusions: Porcine conduits may represent a valuable alternative
to biologic substitutes with similar long-term results. Given the few symp-
toms, progressive conduit stenosis after the eighth postoperative year
imposes a yearly noninvasive patient evaluation during the follow-up. (J
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ter. In addition, some series show a disappointing long-
term outcome of homografts implanted in the pulmonary
circulation.9,10 Other reports have questioned the use of
homograft substitutes in the pediatric population.11
However, whatever the conduit, most patients having
progressive right ventricular outflow tract (RVOT)
obstruction will remain free of symptoms for a long
time.6,12,13
This study was initiated to evaluate retrospectively
the long-term results of porcine valved conduits
implanted as a new RVOT in patients with severe con-
genital ventricular-pulmonary discontinuity.
Patients and methods
Demographics. A cohort of 127 consecutive patients oper-
ated on between July 1973 and December 31, 1996, for com-
plex congenital pulmonary ventricle–pulmonary artery dis-
continuity with implantation of a porcine valved conduit was
available for retrospective analysis.
The ages of the patients ranged from 20 days to 43 years
(mean 5 ± 3.5 years), with 21 patients (16.1%, 70% CL 8%-
24.1%) being younger than 2 years and 72 patients (55.4%,
70% CL 49.5%-61.2%) younger than 6 years of age, as shown
in the distribution depicted in Fig 1. Their weights ranged
from 2.3 to 76 kg (mean 20.4 ± 14.8 kg), 20 patients (15.4%,
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Fig 1. Cumulative distribution plots of age (A) and weight (B) at operation in 127 patients.
70% CL 7.3%-23.4%) weighing less than 10 kg and 88
patients (67.7%, 70% CL 62.8%-72.7%) less than 20 kg at the
time of the operation, as shown in Fig 1. Overall clinical char-
acteristics of patients are displayed in Table I, with stratifica-
tion according to the diagnosis, and a number of preimplanta-
tion palliative procedures are detailed in Table II. Associated
lesions were represented by a right aortic arch in 14 cases, an
anomalous left anterior descending coronary artery originat-
ing from the right in 13 cases, dextrocardia in 10 cases, situs
inversus totalis in 5 cases, an absent pulmonary valve com-
plex in 1 case, and a single right pulmonary artery in 1 case.
Surgical technique. Operations were conducted in a stan-
dard manner with intermittent aortic crossclamping at 25°C
until 1976 and cold crystalloid cardioplegia thereafter (mean
bypass time 138.6 ± 35.5 minutes and mean aortic crossclamp
time 75.2 ± 23 minutes). For conduit implantation, the distal
anastomosis was performed first, and generally before aortic
crossclamping. The valved segment of the conduit was placed
as close to the distal pulmonary artery anastomosis as possi-
ble, and the position of the conduit relative to the ascending
aorta was dictated by the size and the position of the vessel.
A Carpentier-Edwards conduit (Baxter Healthcare Corp,
Edwards Division, Santa Ana, Calif) was implanted in 46
patients and a Hancock conduit (Medtronic, Inc, Minneapolis,
Minn) was implanted in 81 patients, without random assign-
ment. Concomitant aortic valve replacement was performed in
5 patients with truncus arteriosus and truncal valve stenosis or
insufficiency. The distribution of conduit sizes is displayed in
Fig 2, the commonest sizes being 20 mm (38.5% of the cases,
70% CL 31%-45%) and 22 mm (22% of the cases, 70% CL
14%-29%). There was a positive correlation between the sizes
of the conduits and both the age and the weight of the patients
(Fig 3). Since 1986, patients have been subjected to an anti-
coagulation protocol, including heparin for the first postoper-
ative week and aspirin, 100 mg/day, thereafter.
Follow-up. The postoperative evaluation consisted of reg-
ular clinical follow-up at the outpatient clinic, along with ser-
ial echocardiography, magnetic resonance imaging, hemody-
namic assessment, or a combination of these studies,
performed when any anomaly was thought to be related to an
increase in right ventricular–pulmonary artery pressure gra-
dient. Thus 74 postoperative serial hemodynamic studies
were available at some time during the follow-up period, with
a second cardiac catheterization in 24 patients. In 6 patients,
a balloon angioplasty either of the valvular proximal anasto-
motic site or of the distal pulmonary artery stenosis was
attempted, a repeat procedure being performed in 3 instances.
When needed, a second operation for replacement of an ob-
structed conduit was conducted on the basis of lateral chest x-
ray findings. Peripheral cannulation and hypothermia were
used only when there was an obvious narrow relation be-
tween the conduit and the posterior table of the sternum.6
Early mortality was defined as death occurring within 30
days of the operation. For the statistical analysis, data were
entered into a computerized database and analyzed with a sta-
tistical package (STATISTICA, StatSoft, Inc, Tulsa, Okla).
Descriptive summary of data included mean ± standard devi-
ation for continuous variables and proportions for categoric
variables, with levels of significance determined with
Spearman correlation coefficients. Between-group differ-
ences in continuous variables were assessed with t tests and
analysis of variance. The cumulative survival estimates of
patients and survivorship free of reoperation were made by
the Kaplan-Meier method with comparison of 2 or more sur-
vival functions by means of the log-rank test. The 5 variables
considered for univariable analysis were age and weight at
operation, year of operation, initial diagnosis, and conduit
diameter. A multivariable analysis, with the use of the Cox
proportional hazards model, was performed to identify inde-
pendent risk factors for both patient mortality and reoperation
on variables found to be approaching statistical significance
at univariable analysis, with a P value < .05.
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Table I. Initial diagnosis in 127 patients receiving a porcine valved conduit, and summary of early and late
results
Patients
Diagnosis No. % Early deaths Late deaths Reoperation in 103 survivors
TOF-PA 42 33 8 5 7
D-TGV 25 20 3 2 8
Truncus 21 17 9 6 5
DORV 20 16 3 3 5
CTGV 18 14 1 0 0
DOLV 1 0 0 0
Total 127 24 16 25
TOF-PA, Tetralogy of Fallot and pulmonary atresia; d-TGV, D-transposition of the great vessels; CTGV, corrected transposition of the great vessels; DORV, double-
outlet right ventricle. DOLV, double-outlet left ventricle; VSD, ventricular septal defect; PS, pulmonary stenosis.
Table II. Pre-implantation palliative procedures
Procedures No.
Blalock-Taussig shunt 40







Early results. Overall early mortality was 19% (24
patients), the incidence of early deaths being higher in
patients operated on before 1986 (26% vs 13%, c 2, P =
.02), weighing less than 10 kg, or having a conduit
smaller than 18 mm (c 2, P = .008). Inasmuch as the
focus of the study is primarily on long-term results,
early results will not be further detailed.
Patient survival. There were 16 late deaths, which
occurred from 3 months to 17.5 years after the initial
operation (mean 4.6 ± 4 years, median 3.4 years). The
causes of late deaths are listed in Table III, stratified by
initial diagnosis. In the 103 operative survivors, follow-
up ranged from 1 to 21.6 years, with a mean follow-up
of 8.4 ± 6 years (median 7 years, 70% CL 7.7-9 years).
The follow-up was more than 10 years in 33 patients,
(32%, 70% CL 24%-40%) and more than 15 years in 28
patients (27%, 70% CL 19%-35%). Complete follow-
up was obtained in all patients. At univariable analysis,
risk factors for late mortality were year of operation
before 1986, age less than 3 years, and initial diagnosis
of truncus arteriosus (analysis of variance, P = .02).
Actuarial survival, including early mortality, was
72.9% ± 4% at 5 years, 63.1% ± 5% at 10 years, and
58.2% ± 5% at 15 years, at which point 20 patients were
still exposed (Fig. 4). At multivariable analysis, the only
independent risk factors for late mortality were age
younger than 3 years (P = .03) and initial diagnosis of
truncus arteriosus (P = .01), as displayed in Fig. 5.
Hemodynamic data. Sites of conduit obstruction
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Fig 2. Cumulative distribution plot of conduit sizes in millimeters.
Table III. Causes of late deaths in 103 operative survivors
Patient No. Diagnosis Cause Postop time (mo)
1 Truncus At conduit replacement, previous PA banding, severe left PA stenosis 70
2 Truncus RV dysfunction, persistent PAH, truncal valve regurgitation (grade 3) 71
3 Truncus At conduit re-replacement for conduit infection, hemorrhage 72
4 Truncus Accidental (traumatic spleen rupture) 138
5 Truncus RV dysfunction, persistent PAH, truncal valve regurgitation (grade 2) 36
6 Truncus RV dysfunction, persistent PAH, truncal valve regurgitation (grade 2) 3
7 TOF-PA RV dysfunction, single PA 211
8 TOF-PA Acute respiratory distress, absent PA valve 6
9 TOF-PA RV dysfunction, severe left PA stenosis, unilateral right PAH 6
10 TOF-PA Diminutive PAs, localized PAH in 2 lobar territories 96
11 TOF-PA Diminutive PAs, systemic collaterals, repeat hemoptysis 11
12 DORV At conduit re-replacement, hemorrhage 45
13 DORV Persistent LV dysfunction 11
14 DORV Documented ventricular fibrillation 10
15 D-TGV Septic shock and circulatory collapse 3
16 D-TGV Acute conduit obstruction 116
RV, Right ventricle; PA, pulmonary artery; PAH, pulmonary artery hypertension.
were predominantly at the valve level in 10 cases,
behind the sternum as a result of sternal compression in
5 cases, at the proximal anastomosis in 4 cases, and at
the distal site in 3 cases. A significant residual left-to-
right shunt (>2) was found in 3 cases. Postoperative
hemodynamic data (mean peak systolic gradient across
the RVOT and mean peak systolic right ventricular
pressure) were plotted as a function of time. For the pur-
pose of analysis, time between the first operation and
the hemodynamic study was arbitrarily divided into 4
intervals of 4 years. RVOT gradient increased gradual-
ly over time, with a significant step-up after the eighth
postoperative year from 43 ± 36 to 69 ± 19 mm Hg (P
= .04). Meanwhile, the right ventricular pressure,
although generally following the same evolution,
became significantly elevated (P = .01) earlier during
the follow-up, that is, as early as the fourth postopera-
tive year (Fig 6).
Reoperation. Reoperation was required in 25 cases
(24%, 70% CL 15%-33%) for progressive conduit
obstruction confirmed between 1.1 and 17.7 years after
implantation (mean 7.4 ± 4.8 years) in patients with
generally very few symptoms, or for a residual left-to-
right shunt at the ventricular level in 3 patients. Time
interval before reoperation was related only to weight at
the operation, being 6.8 ± 4 years in children weighing
less than 10 kg versus 14.6 ± 0.3 years in patients
weighing more than 10 kg (analysis of variance, P =
.02). Whatever the predominant site of obstruction lead-
ing to reoperation, intimal peel was present to some
extent in all explanted conduits. Obstructed conduits
were replaced by either a new valved substitute (7
cases), a nonvalved substitute (5 cases), or, more recently,
a plain Dacron roofing patch14 (10 cases), with 3 of the
late deaths occurring early after surgery for conduit
replacement (1 case) or re-replacement (2 cases). Thus
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Fig 3. Scattergram and nomogram of regression equation displaying relations between conduit diameter and
weight (A) and age (B) at operation in 127 patients (confidence bands for the 70% confidence intervals).
rates of freedom from reoperation among patients sur-
viving the initial perioperative period were 93.6% ± 2%
at 5 years, 79.5% ± 5% at 10 years, and 65.8% ± 7% at
15 years (Fig 7). Actuarial freedom from reoperation
was not significantly different in patients operated on
before or after 1986 (log-rank test, P = .96). Finally, at
multivariable analysis, initial diagnosis of corrected
transposition of the great vessels, with no patients yet
requiring reoperation, was the only significant predictor
of freedom from reoperation in this patient population (P
= .01). It is noteworthy that 5 female patients who had a
conduit replaced (4 nonvalved and 1 valved) were able
to have normal pregnancies. One of them, with tetralogy
of Fallot and pulmonary atresia, gave birth to a baby who
has since undergone a complete correction of a regular
form of tetralogy of Fallot (anecdotal report).
Finally, no significant difference was detected in the
performance of the two types of conduits used
(Carpentier-Edwards or Hancock) in terms of patient
survival, hemodynamics, or reoperation.
Discussion
The long-term outcome of a variety of substitutes to
treat anatomic ventricular–pulmonary artery discontinu-
ity form the basis of a large and often controversial body
of reference papers in the surgical literature,6,10,12,14,15 a
familiar indicator that the quest for the optimal substitute
still goes on. Moreover, inclusion of different types of
substitutes in most articles makes separate analysis of
data from specific groups of patients more difficult. In
addition, most studies lack extensive hemodynamic
evaluation of porcine composite conduits. In the present
series, the significant increase in the mean peak systolic
right ventricular–pulmonary artery gradient after the
eighth postoperative year is unusually late. This may be
due in part to the rather large sizes of conduits (20 and
22 mm in more than half of the population), whereas the
age distribution is similar to that of most series, except
for large series of neonates and infants with truncus arte-
riosus.16-21 Meanwhile, why a significant change in the
mean peak systolic right ventricular pressure seems to
occur more often early during the follow-up than the
change in gradient remains questionable. A possible
explanation might be found in the presence of a greater
number of patients with elevated pulmonary artery pres-
sure during the earliest hemodynamic evaluations that
were performed for early conduit dysfunction or residual
defects, or both.
The long-term outcome in our series compares favor-
ably with that of others, with freedom from reoperation
for conduit replacement ranging from 94% at 5 years in
the broadest series ever reported on the follow-up of
such RVOT substitutes6,14 to 37% at 5 years in a series
in which more than half of the conduits were less than
18 mm.15 The 5-year freedom from reoperation was
still 60% at 5 years in the largest reported series of
patients with truncus arteriosus, in which 54% of the
124 Hancock conduits implanted were 12 mm.21 Most
patients with truncus in our series were either older
(mean age 33 months, range 23 days–8 years) or had a
previous banding, as more often performed before the
1980s. This may explain why most early deaths among
patients with truncus arteriosus were still due to persis-
tent pulmonary hypertension, particularly at a time
when current pharmacologic assistance was not avail-
able (eg, prostaglandin, nitric oxide). In addition, the
presence of a previous pulmonary artery banding with
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Fig 4. Global actuarial survival, including early mortality. The number of patients exposed at a given time interval
is given in italics.
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Fig 5. Actuarial survival stratified either by age at operation over or under 3 years (A) or by initial diagnosis (B).
Early mortality is excluded in this analysis. CTGV, Corrected transposition of the great vessels; d-TGV, D-transpo-
sition of the great vessels; TOF-PA, tetralogy of Fallot and pulmonary atresia; DORV, double-outlet right ventricle.
Fig 6. Plot of peak systolic right ventricular–pulmonary artery gradient (PSRV-PA) and peak systolic right ven-
tricular pressure (PSRVP) at 4 different 4-year intervals during the follow-up.
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Fig 7. Freedom from reoperation, global (A) or stratified by initial diagnosis (B). CTGV, Corrected transposition
of the great vessels; d-TGV, D-transposition of the great vessels; TOF-PA, tetralogy of Fallot and pulmonary atresia;
DORV, double-outlet right ventricle.
Table IV. Demographics and outcome data collected from published series
Ref No. of No. of porcine No. of Time before Freedom from 
No. First author Year patients conduits Mean age reoperations reoperations reoperation
8 Bailey 1977 85 49 10.2 y 7 70% at 5 y
6 McGoon 1982 468 333 9.8 y 56 94% at 5 y
12 Jonas 1985 201 123 9 y 34 86% at 5 y
24 Bull 1987 249 135 >4 y 23 68% at 5 y
20 Boyce 1988 49 49 3.5 m 28 4.5-101 m NA
15 Sano 1991 141 126 5.9 y 45 37% at 5 y
17 Pearl 1991 32 (TA) 8 3.5 m 5 15-40 m NA
10 Razzouk 1992 457 126 9 y 93 (overall) 89% at 5 y
23 Albert 1993 163 24 4.2 y 6 70% at 5 y
16 Bove 1993 46 (TA) 4 13 d 1 52 m NA
21 Reddy 1995 222 (TA) 124 4 m 52 60% at 5 y
14 Danielson 1995 500 359 9.9 67 94% at 5 y
Reference numbers correspond to those in the reference section. TA, Truncus arteriosus; NA, not available.
stenosis or kinking of the pulmonary bifurcation in-
evitably increased the risk of early and late death, as
well as that of reoperation.
The issue of timing for conduit replacement is very
sensitive. As reported by others, a progressive increase
in right ventricular pressure is usually well tolerated,
and most patients will have a rather mild complaint in
the absence of associated defects.6,13 Given the in-
creased risk of severe conduit stenosis or obstruction
between the fourth and eighth postoperative years in
our series, hemodynamic assessment should be recom-
mended within this time frame. Meanwhile, routine
and eventually repeated catheterization is not well
accepted in the pediatric population. Less invasive fol-
low-up is therefore mandatory, and a good correlation
between echocardiography and hemodynamics has
been demonstrated in patients undergoing RVOT
reconstruction with homografts.13 This should be
extrapolated to porcine conduits, although very little
data are available on this matter. This is one of the rea-
sons that we have recently relied on magnetic reso-
nance imaging, the latest developments in this less
invasive technology allowing an accurate and repeat-
able evaluation of the conduit anatomy (Fig 8).
Interestingly, the probability of reoperation in this
study remains relatively low (6.4% at 5 years and
20.5% at 10 years), particularly since 1986, and the
incidence of late mortality is low as well. Heparin and
aspirin therapies, which were introduced that very year,
potentially explain a difference which, being found
only at univariable analysis, may still be coincidental. 
The traditional alternative to porcine conduit is usually
the aortic or pulmonary homograft, and less than opti-
mal midterm to long-term results have been achieved
with even the latest generation of cryopreserved homo-
grafts in the pediatric population.9-11,22-24 Thus valve
survival was only 46% ± 13% at 5 years in a series of
178 homografts implanted in the RVOT, with similar
performances for aortic or pulmonary homografts.10
Conversely, in a large series of 326 patients with a mean
age of 11.4 years (aortic) and 14.4 years (pulmonary),
freedom from reoperation was similar to that obtained
with porcine conduits (94% at 5 years) when pulmonary
homografts were used, but only 70% with the use of aor-
tic homografts.22 In very small conduits, like the ones
needed for early correction of truncus arteriosus, homo-
grafts may bring the advantages of ease of tailoring and
suturing.21 However, in some countries, difficulties in
collecting small homografts and tight regulations im-
posed on biologic substitutes almost preclude their regu-
lar use. Moreover, in the absence of a truly prospective
comparative study, the advantages of homografts over
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Fig 8. Three-dimensional contrast-enhanced magnetic reso-
nance angiography combining fast 3-dimensional acquisition
and the intravenous injection of paramagnetic contrast media
demonstrating near-normal patency of the right ventricu-
lar–pulmonary artery conduit in a symptom-free patient with
D-transposition and a 20-mm conduit implanted 19 years ear-
lier when the child was 17 months old. The peak systolic
right ventricular-pulmonary artery gradient was 40 mm Hg.
A, Anteroposterior view, with clear representation of the seg-
mental and subsegmental branches of both pulmonary arter-
ies. B, Lateral view, with the same acquisition a bit later
demonstrating the right and left circulations.
porcine conduits even in very young patients remain con-
troversial. Time exposure is still relatively short in most
series, with a mean of 23.4 months19 to 44 months.16 In
most studies, the homograft was an aortic graft that usu-
ally necessitated a gusset augmentation by a piece of
Dacron fabric on the proximal anastomosis, eventually
facilitating the development of later obstruction.17
Finally, avoiding the use of any conduit seems to be
the ideal solution, as first suggested by Lecompte25 and
implemented by other groups in patients with truncus
arteriosus.26,27 However, experiences so far seem limited,
with only 1 long-term oral report in the English litera-
ture (reference 16, discussion). Other more technical
propositions have remained anecdotal in the clinical
field, suggesting the use of either autologous pericardi-
um28,29 or valveless conduits.30
In conclusion, porcine valved conduits used to recon-
struct the RVOT show long-term performances compa-
rable with those of other biologic substitutes in large
sizes. Inasmuch as conduit obstruction has discrete clin-
ical manifestations, careful noninvasive follow-up is
recommended as early as the fourth postoperative year.
We acknowledge D. Revel, MD, Chief of Service, Radi-
ology Department, Hopital Cardiologique, for his expert con-
tribution in magnetic resonance angiography.
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Discussion
Dr Ivan M. Rebeyka (Edmonton, Alberta, Canada). This
retrospective analysis of clinical results with the porcine
valved conduit from Lyon, France, addresses one of the
remaining weak links in surgery for congenital heart disease—
conduit reconstruction of the RVOT. More than 25 years of
clinical experience has been accrued with the use of Dacron
conduits incorporating a porcine valve to achieve right ven-
tricular–pulmonary artery continuity, but unfortunately the
experience with reoperation for conduit obstruction is nearly as
long. An emphasis on complete repair in the neonate may com-
pound the problem by increasing the number of infants at risk
of simply outgrowing their conduits. The 1988 report from Dr
Ebert’s group, which looked specifically at the fate of 12 mm
conduits, is particularly noteworthy in demonstrating that only
about one third lasted more than 5 years. 
The results of this retrospective study indicate that the 94%
rate of freedom from reoperation at 5 years falls to 80% by
10 years, which highlights the false impression of conduit
longevity that short-term follow-up studies might imply. This
is further emphasized by the findings of a significant step-up
in conduit gradient after the eighth year. However, an 80%
survival at 10 years for porcine valved conduits is longer than
virtually all previously reported results with this device. This
survival figure also implies that the porcine conduit outlasts
the aortic homograft in the pulmonary position and may even
outperform the pulmonary homograft. Although primary
autologous reconstruction of the RVOT will be less prone to
late obstruction, right ventricular failure owing to pulmonary
regurgitation would adversely influence the reoperation rate. 
This leads me to my first question. Given these superb late
results with the porcine valved conduit and assuming an
appropriately sized pulmonary homograft was available,
what is your conduit of choice within the RVOT in the infant
age group and in what situations would you opt for a direct
connection between the pulmonary artery and right ventricle? 
Second, you implanted a substantial number of both the
Hancock and the Carpentier-Edwards conduits. Experience
has taught us that subtle differences in valve processing and
construction of bioprosthetic valves can influence durability.
Can you find any difference in the late results when compar-
ing these 2 types of porcine valved conduits? 
Finally, a univariate analysis of your results suggests a
lower incidence of reoperation after 1986 when a protocol of
long-term low-dose aspirin was initiated. Why do you think
platelet-dose aspirin might be effective, considering that pre-
vious studies have supported the concept that progressive
thickening of the lining peel takes place primarily along the
interface between the peel and the conduit rather than the
interface between the peel and the lumen? 
Dr Champsaur. Thank you, Dr Rebeyka. We are well
aware of your participation in some extensive studies coming
from the Toronto group on this particular subject. Regarding
your first question on our current use of conduits in small
infants, we have used homografts for the past 5 years.
However, some countries like ours have tight regulations on
the use of biologic substitutes. These preclude the use of such
small conduits in the infant population. We are no longer
allowed to harvest homografts from nonbeating donors, so
we are still awaiting an ideal substitute. We have in 3
instances used a downsized adult homograft with good early
results, but this is all the hard data I have.
Regarding the comparison between the Hancock and
Carpentier-Edwards, these conduits were not assigned ran-
domly. We used whichever type of conduit was available.
However, we did an analysis and found no statistically sig-
nificant difference between the two substitutes.
Regarding long-term use of low-dose aspirin, this prescrip-
tion was recommended by the cardiologists, but I do not think
there is any scientific ground to support its use. Also, the year
1986 was not an independent predictor of a better outcome.
Thus I do not think that aspirin plays a role in the long-term
outcome.
Dr Stefano Conte (Winksele, Belgium). Considering the
wide spectrum of cardiac anomalies in your series, I think
that your rather high early mortality (19%) has to be consid-
ered more in relation with the difficult repair of complex car-
diac anomalies than with the implantation of the right ven-
tricular conduit in itself. I would like to focus more on the
durability of the porcine conduits, particularly in the group of
patients with tetralogy of Fallot. 
I recently reviewed our experience with pulmonary valve
replacement with cryopreserved homografts in almost 50
patients after previous repair of tetralogy of Fallot or pul-
monary stenosis. Both early and late mortalities were very
low. At a follow-up ranging from 1 to 8 years, we observed no
instances of conduit obstruction or reoperation for pulmonary
valve failure, and only 2 patients has mild pulmonary steno-
sis. 
Although we did not have any instances of midterm con-
duit obstruction, as you did in your series, the mean follow-
up in our series is not long enough yet to allow proper com-
parison with regard to the durability between homograft and
porcine valved conduits. 
However, the reoperation rate of 24% for conduit obstruc-
tion, reported in your study, is considerably higher than the
reoperation rate recently reported in the literature; for exam-
ple, the Toronto group recently reported a reoperation rate of
10%, using mainly porcine conduits and having a follow-up
comparable with yours. Did you find any specific reason for
this difference? 
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Finally, what are your criteria for using or not using a new
valved conduit in the reoperations? In other words, inasmuch
as you did not replace the pulmonary valve in the majority of
the reoperations, do you really believe that the issue of pul-
monary regurgitation and related progressive right ventricular
failure would be less important than pulmonary stenosis in
the setting of further reoperations?
Dr Champsaur. We did look carefully into the literature,
and we found that our reoperation rate was a little lower
than what was previously published. As long as we were
dealing with older children, the results were just about the
same. The 24% reoperation rate you refer to is a crude one.
The actuarial freedom from reoperation was 93% at 5 years
and 80% at 10 years, comparable with those of other pub-
lished series. I think that the great number of large conduits
that we used might explain why this rate is a little better in
our series.
Regarding the second question, at reoperation we prefer to
use a valved conduit if the distal pulmonary artery pressure is
not normal or if there is stenosis or a risk of stenosis that is
not amenable to surgery on the distal pulmonary artery
branches. In those cases, we would choose a valved conduit
rather than a nonvalved conduit.
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